[Skip to Content]
[Skip to Content Landing]
Views 179
Citations 0
Correction
May 2020

Correction to Collaborator’s Name

JAMA Neurol. 2020;77(5):655. doi:10.1001/jamaneurol.2020.0749

The Original Investigation titled “Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial,”1 published online March 2, 2020, was corrected to fix the spelling of a collaborator’s name to Katherine Moretz, which had been incorrectly given as Katherine Mortez in the Group Members section. This article was corrected online.

References
1.
Miller  I, Scheffer  IE, Gunning  B,  et al.  Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in dravet syndrome: a randomized clinical trial.   JAMA Neurol. Published online March 2, 2020. doi:10.1001/jamaneurol.2020.0073Google Scholar
×